The role of long-acting injection in schizophrenia treatment and future challenges

Masakazu Hatano, Hiroyuki Kamei, Nakao Iwata

Research output: Contribution to journalArticle

Abstract

Long-acting injection is a controlled release agent, which was designed that stable blood concentration is provided by giving it once in two to four weeks. Schizophrenia treatment is essential to long-term medication. So, LAI is one of the useful therapeutic strategies. Although traditional LAI had the strong negative impression to be forcibly used for the patients with the refusing medication and the lack of insight into disease, LAI of second-generation antipsychotics are expected to maintenance therapy for the outpatients with Schizophrenia. While psychiatric medical care is shifting from hospitalization to outpatient department, and a role of LAI is important in social rehabilitation. Here, we outline to the clinical importance, characteristic, and future challenge of LAI in psychiatric treatment.

Original languageEnglish
Pages (from-to)186-193
Number of pages8
JournalDrug Delivery System
Volume31
Issue number3
DOIs
Publication statusPublished - 01-01-2016

Fingerprint

Schizophrenia
Injections
Psychiatry
Outpatients
Therapeutics
Antipsychotic Agents
Hospitalization
Rehabilitation

All Science Journal Classification (ASJC) codes

  • Pharmaceutical Science

Cite this

Hatano, Masakazu ; Kamei, Hiroyuki ; Iwata, Nakao. / The role of long-acting injection in schizophrenia treatment and future challenges. In: Drug Delivery System. 2016 ; Vol. 31, No. 3. pp. 186-193.
@article{234030ea04db494dbeeda17b6e1fc78c,
title = "The role of long-acting injection in schizophrenia treatment and future challenges",
abstract = "Long-acting injection is a controlled release agent, which was designed that stable blood concentration is provided by giving it once in two to four weeks. Schizophrenia treatment is essential to long-term medication. So, LAI is one of the useful therapeutic strategies. Although traditional LAI had the strong negative impression to be forcibly used for the patients with the refusing medication and the lack of insight into disease, LAI of second-generation antipsychotics are expected to maintenance therapy for the outpatients with Schizophrenia. While psychiatric medical care is shifting from hospitalization to outpatient department, and a role of LAI is important in social rehabilitation. Here, we outline to the clinical importance, characteristic, and future challenge of LAI in psychiatric treatment.",
author = "Masakazu Hatano and Hiroyuki Kamei and Nakao Iwata",
year = "2016",
month = "1",
day = "1",
doi = "10.2745/dds.31.186",
language = "English",
volume = "31",
pages = "186--193",
journal = "Drug Delivery System",
issn = "0913-5006",
publisher = "Japan Society of Drug Delivery System",
number = "3",

}

The role of long-acting injection in schizophrenia treatment and future challenges. / Hatano, Masakazu; Kamei, Hiroyuki; Iwata, Nakao.

In: Drug Delivery System, Vol. 31, No. 3, 01.01.2016, p. 186-193.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The role of long-acting injection in schizophrenia treatment and future challenges

AU - Hatano, Masakazu

AU - Kamei, Hiroyuki

AU - Iwata, Nakao

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Long-acting injection is a controlled release agent, which was designed that stable blood concentration is provided by giving it once in two to four weeks. Schizophrenia treatment is essential to long-term medication. So, LAI is one of the useful therapeutic strategies. Although traditional LAI had the strong negative impression to be forcibly used for the patients with the refusing medication and the lack of insight into disease, LAI of second-generation antipsychotics are expected to maintenance therapy for the outpatients with Schizophrenia. While psychiatric medical care is shifting from hospitalization to outpatient department, and a role of LAI is important in social rehabilitation. Here, we outline to the clinical importance, characteristic, and future challenge of LAI in psychiatric treatment.

AB - Long-acting injection is a controlled release agent, which was designed that stable blood concentration is provided by giving it once in two to four weeks. Schizophrenia treatment is essential to long-term medication. So, LAI is one of the useful therapeutic strategies. Although traditional LAI had the strong negative impression to be forcibly used for the patients with the refusing medication and the lack of insight into disease, LAI of second-generation antipsychotics are expected to maintenance therapy for the outpatients with Schizophrenia. While psychiatric medical care is shifting from hospitalization to outpatient department, and a role of LAI is important in social rehabilitation. Here, we outline to the clinical importance, characteristic, and future challenge of LAI in psychiatric treatment.

UR - http://www.scopus.com/inward/record.url?scp=84992505449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992505449&partnerID=8YFLogxK

U2 - 10.2745/dds.31.186

DO - 10.2745/dds.31.186

M3 - Article

AN - SCOPUS:84992505449

VL - 31

SP - 186

EP - 193

JO - Drug Delivery System

JF - Drug Delivery System

SN - 0913-5006

IS - 3

ER -